Net Income Summary of ResMed Inc.

ResMed Inc.'s latest annual net income in 2024 was 1.02 Billion USD , up 13.75% from previous year.
ResMed Inc.'s latest quarterly net income in 2024 FY was 1.02 Billion USD , up 13.75% from previous quarter.
ResMed Inc. reported an annual net income of 897.55 Million USD in 2023, up 89.16% from previous year.
ResMed Inc. reported an annual net income of 474.5 Million USD in 2022, down 0.0% from previous year.
ResMed Inc. reported a quarterly net income of 1.02 Billion USD for 2024 FY, up 13.75% from previous quarter.
ResMed Inc. reported a quarterly net income of 292.23 Million USD for 2024 Q4, down -2.75% from previous quarter.

Annual Net Income Chart of ResMed Inc. (2024 - 1993)

Historical Annual Net Income of ResMed Inc. (2024 - 1993)

Year	Net Income	Net Income Growth
2024	1.02 Billion USD	13.75%
2023	897.55 Million USD	89.16%
2022	474.5 Million USD	0.0%
2021	474.5 Million USD	17.28%
2020	404.59 Million USD	0.0%
2019	404.59 Million USD	28.2%
2018	315.58 Million USD	-7.8%
2017	342.28 Million USD	-2.87%
2016	352.4 Million USD	-0.14%
2015	352.88 Million USD	2.2%
2014	345.27 Million USD	12.42%
2013	307.13 Million USD	20.52%
2012	254.85 Million USD	12.28%
2011	226.98 Million USD	19.41%
2010	190.08 Million USD	29.8%
2009	146.44 Million USD	32.77%
2008	110.3 Million USD	66.36%
2007	66.3 Million USD	-24.84%
2006	88.21 Million USD	36.16%
2005	64.78 Million USD	13.09%
2004	57.28 Million USD	25.27%
2003	45.72 Million USD	21.92%
2002	37.5 Million USD	222.49%
2001	11.63 Million USD	-47.67%
2000	22.22 Million USD	38.05%
1999	16.1 Million USD	51.89%
1998	10.6 Million USD	41.33%
1997	7.5 Million USD	66.67%
1996	4.5 Million USD	60.71%
1995	2.8 Million USD	133.33%
1994	1.2 Million USD	50.0%
1993	800 Thousand USD	0.0%

Year	Net Income	Net Income Growth
2024 Q1	219.42 Million USD	-4.46%
2024 FY	1.02 Billion USD	13.75%
2024 Q4	292.23 Million USD	-2.75%
2024 Q3	300.49 Million USD	43.91%
2024 Q2	208.8 Million USD	-4.84%
2023 Q2	224.91 Million USD	6.86%
2023 Q3	232.5 Million USD	3.37%
2023 Q4	229.66 Million USD	-1.22%
2023 Q1	210.47 Million USD	7.9%
2023 FY	897.55 Million USD	89.16%
2022 Q3	179.01 Million USD	-11.27%
2022 Q4	195.06 Million USD	8.97%
2022 Q1	203.61 Million USD	4.36%
2022 FY	474.5 Million USD	0.0%
2022 Q2	201.75 Million USD	-0.91%
2021 Q4	195.1 Million USD	348.6%
2021 FY	474.5 Million USD	17.28%
2021 Q1	178.37 Million USD	0.3%
2021 Q2	179.51 Million USD	0.64%
2021 Q3	-78.48 Million USD	-143.72%
2020 Q3	163.13 Million USD	1.61%
2020 Q4	177.83 Million USD	9.01%
2020 FY	404.59 Million USD	0.0%
2020 Q2	160.55 Million USD	33.63%
2020 Q1	120.14 Million USD	74.63%
2019 Q2	124.63 Million USD	17.88%
2019 Q4	68.8 Million USD	-34.73%
2019 Q3	105.41 Million USD	-15.42%
2019 FY	404.59 Million USD	28.2%
2019 Q1	105.73 Million USD	-3.71%
2018 Q1	86.12 Million USD	-15.24%
2018 FY	315.58 Million USD	-7.8%
2018 Q4	109.81 Million USD	-0.29%
2018 Q3	110.12 Million USD	1055.93%
2018 Q2	9.52 Million USD	-88.94%
2017 Q3	87.82 Million USD	14.44%
2017 Q4	101.61 Million USD	15.7%
2017 FY	342.28 Million USD	-2.87%
2017 Q1	76.1 Million USD	-18.19%
2017 Q2	76.74 Million USD	0.84%
2016 Q4	93.03 Million USD	2.47%
2016 Q3	90.79 Million USD	-5.01%
2016 Q1	82.91 Million USD	-5.2%
2016 Q2	95.57 Million USD	15.27%
2016 FY	352.4 Million USD	-0.14%
2015 Q3	90.98 Million USD	-0.22%
2015 FY	352.88 Million USD	2.2%
2015 Q1	83.26 Million USD	-5.1%
2015 Q2	91.18 Million USD	9.51%
2015 Q4	87.46 Million USD	-3.87%
2014 Q1	80.93 Million USD	10.84%
2014 Q4	87.73 Million USD	-2.48%
2014 FY	345.27 Million USD	12.42%
2014 Q3	89.96 Million USD	3.85%
2014 Q2	86.63 Million USD	7.05%
2013 Q1	71.26 Million USD	-7.26%
2013 Q4	73.01 Million USD	-14.01%
2013 FY	307.13 Million USD	20.52%
2013 Q3	84.91 Million USD	8.94%
2013 Q2	77.94 Million USD	9.37%
2012 Q4	76.84 Million USD	18.93%
2012 Q2	62.87 Million USD	24.45%
2012 Q3	64.61 Million USD	2.77%
2012 Q1	50.51 Million USD	-13.6%
2012 FY	254.85 Million USD	12.28%
2011 Q2	58.45 Million USD	3.08%
2011 FY	226.98 Million USD	19.41%
2011 Q4	58.47 Million USD	-65.3%
2011 Q3	168.51 Million USD	188.27%
2011 Q1	56.7 Million USD	6.66%
2010 Q2	45.98 Million USD	9.22%
2010 Q1	42.1 Million USD	-7.2%
2010 Q4	53.16 Million USD	8.87%
2010 Q3	48.83 Million USD	6.2%
2010 FY	190.08 Million USD	29.8%
2009 FY	146.44 Million USD	32.77%
2009 Q4	45.37 Million USD	15.75%
2009 Q3	39.19 Million USD	15.79%
2009 Q2	33.85 Million USD	20.79%
2009 Q1	28.02 Million USD	-5.43%
2008 Q4	29.63 Million USD	-0.17%
2008 Q1	24.12 Million USD	-12.82%
2008 Q2	26.86 Million USD	11.34%
2008 Q3	29.68 Million USD	10.51%
2008 FY	110.3 Million USD	66.36%
2007 FY	66.3 Million USD	-24.84%
2007 Q4	27.67 Million USD	280.1%
2007 Q3	-15.36 Million USD	-152.99%
2007 Q2	28.99 Million USD	15.98%
2007 Q1	24.99 Million USD	8.25%
2006 FY	88.21 Million USD	36.16%
2006 Q2	22.31 Million USD	35.71%
2006 Q1	16.44 Million USD	5.55%
2006 Q3	26.36 Million USD	18.14%
2006 Q4	23.09 Million USD	-12.4%
2005 Q3	17.87 Million USD	2.72%
2005 Q1	13.92 Million USD	-12.17%
2005 Q2	17.4 Million USD	24.97%
2005 Q4	15.57 Million USD	-12.86%
2005 FY	64.78 Million USD	13.09%
2004 Q2	14.15 Million USD	15.53%
2004 FY	57.28 Million USD	25.27%
2004 Q3	15.02 Million USD	6.2%
2004 Q4	15.85 Million USD	5.5%
2004 Q1	12.24 Million USD	-9.43%
2003 Q3	12.25 Million USD	17.97%
2003 Q2	10.38 Million USD	8.49%
2003 Q1	9.57 Million USD	-2.44%
2003 FY	45.72 Million USD	21.92%
2003 Q4	13.52 Million USD	10.4%
2002 Q1	8.53 Million USD	2.3%
2002 Q2	8.77 Million USD	2.82%
2002 FY	37.5 Million USD	222.49%
2002 Q3	10.37 Million USD	18.23%
2002 Q4	9.81 Million USD	-5.48%
2001 Q4	8.34 Million USD	181.87%
2001 Q1	6.58 Million USD	6.28%
2001 Q2	6.89 Million USD	4.83%
2001 FY	11.63 Million USD	-47.67%
2001 Q3	-10.19 Million USD	-247.78%
2000 Q3	5.83 Million USD	8.11%
2000 Q4	6.19 Million USD	6.05%
2000 Q2	5.4 Million USD	12.5%
2000 FY	22.22 Million USD	38.05%
2000 Q1	4.8 Million USD	4.35%
1999 FY	16.1 Million USD	51.89%
1999 Q4	4.6 Million USD	4.55%
1999 Q3	4.4 Million USD	12.82%
1999 Q2	3.9 Million USD	21.88%
1999 Q1	3.2 Million USD	6.67%
1998 Q3	3.1 Million USD	34.78%
1998 Q2	2.3 Million USD	4.55%
1998 Q4	3 Million USD	-3.23%
1998 FY	10.6 Million USD	41.33%
1998 Q1	2.2 Million USD	4.76%
1997 Q2	1.7 Million USD	-5.56%
1997 Q3	1.9 Million USD	11.76%
1997 FY	7.5 Million USD	66.67%
1997 Q4	2.1 Million USD	10.53%
1997 Q1	1.8 Million USD	20.0%
1996 Q1	900 Thousand USD	28.57%
1996 Q3	1.2 Million USD	33.33%
1996 Q4	1.5 Million USD	25.0%
1996 FY	4.5 Million USD	60.71%
1996 Q2	900 Thousand USD	0.0%
1995 Q2	700 Thousand USD	0.0%
1995 Q1	700 Thousand USD	133.33%
1995 FY	2.8 Million USD	133.33%
1995 Q4	700 Thousand USD	0.0%
1995 Q3	700 Thousand USD	0.0%
1994 Q1	300 Thousand USD	50.0%
1994 Q3	300 Thousand USD	0.0%
1994 FY	1.2 Million USD	50.0%
1994 Q4	300 Thousand USD	0.0%
1994 Q2	300 Thousand USD	0.0%
1993 Q1	200 Thousand USD	0.0%
1993 FY	800 Thousand USD	0.0%
1993 Q4	200 Thousand USD	0.0%
1993 Q3	200 Thousand USD	0.0%
1993 Q2	200 Thousand USD	0.0%

Peer Net Income Comparison of ResMed Inc.

Name	Net Income	Net Income Difference
Austco Healthcare Limited	7.07 Million AUD	-14328.363%
Nanosonics Limited	12.97 Million AUD	-7770.421%
Osteopore Limited	-4.87 Million AUD	21055.562%
SDI Limited	10.42 Million AUD	-9697.054%
Trajan Group Holdings Limited	-25.32 Million AUD	4130.759%

Global Stocks Search

ResMed Inc. (RMD.AX)

Net Income Summary of ResMed Inc.

Annual Net Income Chart of ResMed Inc. (2024 - 1993)

Historical Annual Net Income of ResMed Inc. (2024 - 1993)

Peer Net Income Comparison of ResMed Inc.